Carboplatin/Liposomal Doxorubicin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Carboplatin/Liposomal Doxorubicin, covering 2023-03-27 to 2023-03-27. Get the full timeline:
Most recent: Clinical Trial Update: MITO-2: A Study Comparing 2 Chemotherapy Regimens (Carboplatin/Liposomal Doxorubicin vs Carboplatin/Paclitaxel) in Patients With Ovarian Cancer [Phase 3]